Announcement on the Holding Subsidiary's Obtaining of the "Drug GMP Certificate"
Release time:
2020-08-05
Securities Code: 600668 Securities Short Name: Jianfeng Group Announcement No.: Pro 2018-026
Bond Short Name: 13 Jianfeng 02 Bond Code: 122344
Announcement of Zhejiang Jianfeng Group Co., Ltd.
on the acquisition of the "Drug GMP Certificate" by the holding subsidiary
The board of directors and all directors of the company guarantee this announcement There are no false records, misleading statements or major omissions, and they are individually and jointly liable for the authenticity, accuracy and completeness of their contents.
Recently, Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the company") holding subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical") received Zhejiang Food The "Drug GMP Certificate" issued by the Drug Administration. The relevant information is hereby announced as follows:
1. GMP Certification Related Information
Enterprise Name: Zhejiang Jianfeng Pharmaceutical Co., Ltd.
Address: No.
Certificate No.: No. 368 Jinqu Road, Jinhua Industrial Park, Zhejiang Province: ZJ20180081
Certification Scope: Eye Drops, Ear Drops
Valid: august 2, 2023
2. involves production line capacity and main products:
Production Line Name |
Design Annual Capacity |
Variety |
Eye Drops Production Line |
Million |
Sodium Hyaluronate Eye Drops |
Ear Drops Production Line |
.5 Million |
Ofloxacin Ear Drops |
Market Situation of Main Products of 3. Company
Drug Name |
Dosage Form |
functional indications |
main manufacturer |
sodium hyaluronate eye drops |
eye drops |
are used for Sjogren's syndrome, Sjogren's syndrome, xerophthalmia |
towering pharmaceutical (China) co., ltd ; Qilu Pharmaceutical Co., Ltd.; Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch; |
Ofloxacin Ear Drops |
Ear Drops |
is used to treat otitis media, otitis externa and tympanitis caused by sensitive bacteria |
Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd; Nanjing Tianlang Pharmaceutical Co., Ltd.; Wuhan Wujing Pharmaceutical Co., Ltd.; |
Note: 1. The information of "Main Manufacturers" in the fourth column of the table mainly comes from the website of china food and drug administration.
2, 2017, peak pharmaceutical sodium hyaluronate eye drops sales revenue of 15.9176 million yuan, the sales revenue of ofloxacin ear drops was 1.2665 million yuan.
Impact of 4. on Listed Companies and Risk Tips
The "Drug GMP Certificate" obtained by Jianfeng Pharmaceutical this time is not the certification certificate of the new production line, but the certificate obtained after the GMP certificate of its original eye drop and ear drop production line expires and is re-certified. Obtaining the GMP certificate again will help ensure the product quality and production capacity of Jianfeng Pharmaceutical, ensure market supply, and will not have a significant impact on the company's current operations. The specific future sales of various drugs of
Company may be affected by market environment, industry policy, supply and demand relationship and other factors, with uncertainty. Please the majority of investors cautious decision-making, pay attention to prevent investment risk.
is hereby announced.
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
August 14, 2018
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page